Find out more about the NICE Medical Technologies Advisory Committee members by reading their biographies.

Professor Peter Groves


Professor Peter Groves is a Consultant Interventional Cardiologist based at the University Hospital of Wales, Cardiff since 1996. He served as Clinical Director of Cardiothoracic Services from 2002 to 2009. Professor Groves undertakes percutaneous cardiac procedures for structural and coronary heart disease and leads the Structural Heart Disease Interventional Programme in South-East Wales.

Professor Groves qualified from the University of Newcastle-Upon-Tyne Medical School in 1984 MBBS (Hons). He completed General Medical training in the Newcastle University Hospitals culminating in MRCP and began his specialist Cardiology training in Cardiff in 1988. He undertook Cardiovascular scientific and clinical research in Cardiff (BHF Fellowship; MD awarded by the University of Newcastle-Upon-Tyne in 1993) and at the University of Freiburg (Alexander von Humboldt Scholar). Professor Groves was Senior Registrar in Cardiology at the Royal Brompton and National Heart Hospital, London 1994-1996.

Professor Groves is past-President of the Welsh Cardiovascular Society and previous Council member of the British Cardiovascular Society. He represents the Welsh Government as the chairman of the MHRA Devices Expert Advisory Committee (DEAC) and has worked with NICE since 2006. He served as a Committee member on the Interventional Procedures Advisory Committee (2006-2009) and then joined the Medical Technologies Advisory Committee in 2009, serving as the inaugural Vice-Chairman of the Committee from 2009-2015.

Professor Groves was appointed as Chair of the Medical Technologies Advisory Committee in 2016.

Professor Fiona Denison


Fiona Denison is a Professor of Translational Obstetrics at the University Edinburgh of MRC. She holds a clinical academic and obstetric lead for maternal obesity. She has a specific interest in the design and development of innovative new technologies for clinical care across a range of specialties including obstetrics, midwifery and anaesthetics.

Dr Mike Burrows

Mike Burrows is the National AHSN Network Coordination Director. Until recently he was the Managing Director of the Greater Manchester Academic Health Science Network (AHSN). Previously he was the Director of the NHS England (Greater Manchester) Area Team, a role that followed on from that of Chief Executive of NHS Greater Manchester. From May 2004 until May 2011 he was Chief Executive of Salford Teaching Primary Care Trust.

Originally a Doctor of Biochemistry, Mike has worked in the NHS for 31 years now, both in the finance discipline and general management. He has an active interest in the use of evidence based medicine and a passionate believer in the benefits of strong ties between the NHS and academia. In this respect he was one of the founding board members of the Manchester Academic Health Sciences Centre (MAHSC) and under his leadership developed Salford PCT to be one of the leading research active PCTs in the country.

In his current role, Mike has the responsibility for engaging the NHS, academia and industry to generate health and wealth, particularly through the adoption and diffusion of innovation and research output.

In his previous role as the Chief Executive of NHS Greater Manchester Mike shaped the concept of a major programme of service transformation in Greater Manchester entitled ‘Healthier Together’ which is now being led and delivered by the 12 CCGs.

Mike is the Deputy Chairman of the University of Salford.

Mr Julian Dunnett

Julian Dunnett works at Intuitive. He’s the Director for Global Access, Value and Economics for UK, Ireland and Medtech EU. Intuitive is a patient-focused company which manufactures the da Vinci surgical system and the ion endoluminal system.

Since joining Intuitive in 2014, Julian has represented the medical device industry in a range of roles. He’s been an industry representative on NHS Digital’s national casemix office advisory board and also Vice Chair of the market access and economic policies committee at Medtech Europe.

After leaving the Royal Air Force in 2001, Julian worked for several medical device companies including Olympus, Smith & Nephew Orthopaedics and American Medical Systems.

Julian has gained a broad range of experience across a number of healthcare specialties including: gastroenterology; urology; ear, nose and throat; reconstructive orthopaedics; colorectal surgery; general surgery; gynaecology surgery; head and neck surgery and thoracic surgery.

Julian has held regional and national management roles in commercial areas like sales and business development, before focussing more on market access and government affairs roles: roles he has undertaken with both national and international responsibility.

Julian has a BA (Hons) degree in philosophy and music and an MA in musicology, both from the University of Southampton. In addition, Julian has a postgraduate certificate in health economics from the University of Aberdeen.

Dr Teik Goh

Teik Goh is currently a GP Partner at The Garth Surgery in Guisborough a market town on the edge of North Yorkshire. Until recently, he worked as GP with special interest in older people in County Durham, and was the inaugural Medical Director then CEO/MD of ELM Alliance Ltd, the South Tees GP Federation of 43 general practices.

In his previous roles, Teik led the setting up of research network of 15 practices, extended hours and out-of-hour service as well as an innovative care home enhanced support service. In his current roles, Teik is the GP lead for the community prehabilitation project – one stop preoperative programme to improve patient fitness prior to surgery.

Teik completed MSc in Health Management at Imperial College London Business School, did health economics research at the University of Aberdeen and health services research at Newcastle University, before completing his GP training in the North East. He maintains interest in primary care research and implementation in general practice.

Mr Stephen Habgood

Stephen Habgood is licensed as an anglican priest within the Diocese of Lichfield and a retired senior prison governor.

Whilst a prison governor he served in several prisons, including an open prison, a training prison, a high-security prison and a juvenile establishment. He was at one time responsible for managing the contracts for all prisoner movement in England and Wales. He retired after almost 30 years service following the suicide of his only son in 2009. He then spent 9 years as chairman of the charity PAPYRUS Prevention of Young Suicide, retiring in June 2019. During his time with the prison service he obtained an MBA from the Open University and an MSt from Cambridge University to go with his Diploma in Theology from Cardiff University.

He has been a lay member on two guideline committees; the mental healthcare of those in the criminal justice system and suicide prevention in the community and custody settings. He also reviews research proposals for the National Institute for Health Research.

He is a director of a CIC called 'Making Families Count'. They hold workshops to encourage NHS Trust senior managers to engage more with families in the investigation of suicides, homicides and the deaths of those with autism or learning difficulties, and to better engage with families in the provision of treatment and care.

Professor Shaheen Hamdy

Professor Shaheen Hamdy is currently a Professor in Medicine (Neurogastroenterology) within the University of Manchester, Centre Lead for GI Sciences, Institute of Inflammation and Repair and Director of the Neuroscience Research Institute. He holds a clinical academic contract, delivering clinical care at Salford Royal Hospital NHS Trust for 50% of his contracted time. He is also lead academic clinician for the NIHR academic training programme in Gastroenterology at the University of Manchester. He sat on the HTA EDaPT panel from 2008-2011 and is chair of the Neurogastroenterology and Motility Committee Section of the British Society of Gastroenterology.

Dr Jeremy Henning

Jeremy is currently a consultant in intensive care medicine at the James Cook University Hospital, Middlesbrough. He gained his degrees from the University Of Wales in Cardiff, and did much of his registrar training in Wessex and the South West of England. He has special interests in trauma care and bioethics.

He has recently retired from the British Army where he was the clinical lead for military intensive care for several years, introducing it as a specialty in its own right, and deploying on several operational tours. He has contributed to several national reports and audits, including our guidance on adult emergency care. He holds 2 honorary lecturer posts and is an examiner for the Faculty of Intensive Care Medicine.

Mr Chris Hudson

Chris joined Roche in 1998 as Marketing Manager, Patient Monitoring for UK & Ireland. This business unit included diabetes and point of care products used in both the hospital and the community.

In the last 16 years Chris has held a number of senior leadership positions with Roche both in the UK and globally. This started in 2001 as Business Unit Director of Patient Monitoring and a subsequent move in 2005 to Director of Diabetes Care UK. In 2007 he moved to the global business unit of diabetes care in Germany as Head of Commercial Marketing and became the Head of Blood Glucose Monitoring Marketing in the Roche diabetes care global organisation in 2009.

In 2012, Chris returned to the UK as Director of Roche tissue diagnostics, before becoming Director of the newly formed directorate of Healthcare Development and Strategic Services in 2015. This directorate encompasses the functions of:

  • medical affairs
  • public affairs
  • communications
  • market access (incorporating health economics)
  • strategic accounts
  • marketing for services and consulting
  • managed laboratory service sales
  • the agency businesses in Israel, Malta, Iceland and Cyprus.

Prior to joining Roche, Chris worked in marketing and sales for several international healthcare companies both in the UK and USA.

Outside of Roche, Chris is currently an executive committee member of BIVDA (British In Vitro Diagnostics Association) and the Diagnostic Industry Representative on the MTAC (Medical Technologies Advisory Committee) for NICE.

Dr Cynthia Iglesias

Cynthia Iglesias is senior health economist/ health services researcher at the University of York. She has a first degree in Actuary from the National Autonomous University of Mexico, a MSc in Health Economics and a PhD in Health Services Research, both from the University of York. Cynthia is based at the Department of Health Sciences, and has had honorary appointments with the Hull and York Medical School and the Centre for Health Economics, where she is now an internal affiliate.

Cynthia's main areas of interest are economic evaluation of healthcare technologies; its contribution to healthcare policy decision making and Bayesian Sandy Newbystatistical methods for economic evaluation. In 2008, she started a personal fellowship awarded by the Medical Research Council to look at the potential contribution of Bayesian methods for evidence synthesis to the evaluation of therapeutic medical devices.

Professor Mohammad Ilyas

Mohammad Ilyas is Professor of Pathology at Nottingham University and Honorary Consultant in Pathology at Nottingham University Hospitals NHS Trust. His research interests are focused mainly on the genetic basis of cancer and inflammatory diseases of the gastrointestinal tract. As well as basic cell and molecular biology, he has research interests in the development of molecular diagnostics and has developed protocols for High Resolution Melting analysis (following PCR) to facilitate mutation detection.

Mohammad is on the editorial board of several journals and a founding member of the newly formed Association of Clinical Pathologists Molecular Pathology and Diagnostics group. He has previously worked with NICE on the Colorectal Cancer Guidelines Development Group and the Topic Experts Group used to develop standards from the guidelines. He was a member of the former NICE Topic Selection Consideration panel and he has also provided consultation to NICE on behalf of the Royal College of Pathologists on technology appraisals.

Ms Emily Lam

Ms Emily Lam was a registered nurse and obtained a BA (Honours) degree in Psychology through the Open University. After leaving the NHS, Ms Lam set up an education consultancy service that ran for fourteen years.   

As a non-executive director of a primary care trust Ms Lam involved users, carers and community organisations in developing quality monitoring and evaluation work. In 2013, while Ms Lam was a lay member on the NICE Guideline Development Group for Chronic Hepatitis B, she initiated a series of chronic hepatitis B health education activities in Manchester in the Chinese community. The work culminated in some local individuals testing positive, and receiving treatment for this asymptomatic but potentially lethal disease. 

Over the last sixteen years or so, as a result of serious health problems, Ms Lam has undergone various investigative procedures and this has brought her into close contact with advanced medical technologies. Emily hopes that her understanding and experience as a patient can add value to the discussions and evaluation of potential innovative medical technologies competing for NHS resources.

Dr Avril McCarthy

Avril McCarthy is a Lead Clinical Scientist, within Clinical Engineering at Sheffield Teaching Hospitals NHS Foundation Trust. She leads its successful medical device innovation team, in which device risk management and regulatory compliance are a significant part of her role.

She began her NHS career as a biomedical scientist in haematology before furthering her interest in biomechanics and human factors. Avril was awarded a PhD in 2001 from the Faculty of Engineering at the University of Sheffield for developing and evaluating minimal access orthopaedic ‘virtual environments’ for surgical training. This was followed by several years of EU-funded collaborative research into orthopaedic soft tissue implants involving a number of major medical device, engineering and IT companies.

A founding member of the National Institute for Health Research (NIHR) Devices for Dignity (D4D) HTC since 2008, she has been its MedTech lead, supporting a portfolio of new technologies from incontinence products, to assistive, rehabilitative and renal technologies. She was awarded an Honorary Senior Research Fellowship in 2014 by the School of Health and Related Research (ScHARR) at the University of Sheffield and has been a lead or co-investigator on several NIHR device studies.

Dr Karen McCutcheon

Dr Karen McCutcheon is a registered nurse and a senior lecturer at Queen’s University Belfast, School of Nursing and Midwifery. She is responsible for anaesthetic, perioperative and ophthalmic nurse training and is the academic lead for practice and assessment for undergraduate nursing.

She has published widely in the field of healthcare and education and is the editor of the Journal of Perioperative Practice and is the nurse section editor for BMJ onExamination. She served as a member of the Interventional Procedures Advisory Committee (2006-2016) and has participated in the development of a number of National Patient Safety guidelines in the UK.

Mr Abdullah Pandor

Abdullah Pandor is a Senior Research Fellow in systematic reviewing at the School of Health and Related Research (ScHARR), within the University of Sheffield. He is the Director of ScHARR-TAG Reviews, an academic group which is involved in the production of evidence reports to support health policy decision making by NICE and other national bodies. Abdullah has undertaken research on the clinical effectiveness of healthcare technologies for the National Institute for Health Research (NIHR) Health Technology Assessment Programme for over 15 years and has been involved with the NICE Decision Support Unit.

His research interests include the application and development of systematic review methods. In particular, the review and synthesis of diagnostic and prognostic evaluations, rapid reviews, review techniques for individual patient data and mixed treatment comparisons.

Dr David Partridge

Dr David Partridge is a Consultant Medical Microbiologist and Infection Control Doctor at Sheffield Teaching Hospital NHS Foundation Trust. He is research lead for the Directorate of Laboratory Medicine at the Trust and also sits on the management committee of the Florey Institute for Host-Pathogen Interaction at the University of Sheffield. His clinical interests lie in medical mycology, infections of the immunocompromised host and molecular bacteriology.

He has served as a council member for the British Infection Association since 2009 (as trainee member, membership secretary and finally communications secretary) and also sat on the grants committee of the Healthcare Infection Society from 2015 to 2018.

Dr Jai Patel

Dr Jai Patel is a consultant in vascular and interventional radiology at Leeds Teaching Hospitals NHS Trust (LTHT), appointed in 1999. Together with his colleagues, he provides one of the largest and most comprehensive adult and paediatric vascular interventional radiology services within the UK.

His main areas of clinical interest are in trans-arterial therapies for the treatment of liver tumours, radiological management of portal hypertension and treatment of vascular malformations. He was previously Lead Clinician for vascular radiology at LTHT for 5 years and is currently Deputy Training Programme Director for the West Yorkshire Radiology Training Scheme.

He has previously undertaken national committee work as Education Committee Chair and, more recently, Secretary of the British Society of Interventional Radiology (BSIR). During his time as BSIR Secretary, he provided stakeholder comments on a range of relevant NICE draft Interventional Procedures Guidance and Technology Appraisals.

Professor Carl Roobottom

Carl Roobottom is Professor of Radiology at Derriford Hospital Plymouth and Head of the Peninsula Radiology Academy. He was a mechanical engineer before he decided to pursue a career in medicine. After obtaining a first class degree in Pathology, and honours in Medicine, he obtained Membership of the Royal Colleges of Physicians, then trained as a radiologist.

His initial interest was in interventional radiology. Through the British Society of Interventional Radiology he helped set up a national registry system for new procedures.

Over the last decade he has been pivotal in the development of Cardiac Computed Tomographic Angiography (CTCA), transforming it from a niche research application to a NICE first line investigation for all patients with stable chest pain. He has been a council member of the British Society of Cardiac Imaging for over 10 years.

Carl has previous experience with NICE and has advised on diagnostic guidance guidelines as well as the recent update on cardiac chest pain.

Mr Andrew Thorpe

Andrew is a Consultant Urologist at the Freeman Hospital, Newcastle upon Tyne. He qualified in Medicine at the University Hospital of Wales, Cardiff in 1981. He trained in Surgery at Cardiff, St Thomas' Hospital London and the Royal London Hospital. He completed an M.Ch. thesis on pelvic floor dysfunction and then went on to train in Urology at the Royal London Hospital, The Royal Berkshire Hospital, Reading and the Freeman Hospital, Newcastle upon Tyne.

Andrew Thorpe's main clinical interests include bladder cancer, bladder dysfunction and urinary incontinence, and new technology for men with bladder outflow obstruction.

His major research areas have been in bladder cancer, urinary incontinence and improving clinical outcomes after radical cystectomy for bladder cancer.

He is a past Honorary Secretary of the British Association of Urological Surgeons (BAUS), a past secretary to the Female Urology Subsection of BAUS, and currently sits on the NIHR Interventional Procedures Panel.

He has acted as an expert witness to the NICE MTAC panel in the past for new procedures to treat bladder outflow obstruction in men.

Professor Allan Wailoo

Allan Wailoo is Professor of Health Economics in the School of Health and Related Research (ScHARR). He is Director of the NICE Decision Support Unit which provides expert research and training support to the Technology Appraisals Programme at NICE. He has interests in all areas of economic evaluation and the analysis of patient level data to inform cost effectiveness models, particularly around health utilities.

Allan has published applied research in a wide range of disease areas. He is a member of the Department of Health's Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) based in Sheffield/York and provides advice to the local NHS as part of the Research Design Service for Yorkshire and the Humber.

He joined the MTAC in January 2012.

Mr Alun Williams

Alun Williams is a consultant in transplant surgery and paediatric and adolescent urology at Nottingham University Hospitals. He is co-lead for paediatric transplantation and also for the living donor kidney transplant programme there. Transition and long-term care of congenital problems are further special interests.

He has been a member of the NICE guideline development groups for lower urinary tract dysfunction in neurological disease and for transition from paediatric to adult care, and was also a member of the committee developing quality standards for transition. He was a NICE fellow from 2013 - 16.

Alun’s extracurricular life involves music (clarinet and early music) and horses, although not usually at the same time.

More information

Find out more about the committee and read papers from previous meetings.

About the Medical Technologies Advisory Committee


Get involved

Find out when MTAC meetings are held and register to attend.